|
Lung Cancer Research Foundation
|
New York, NY
|
$150
|
Improves lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer.
|
2022
|
|
Amanda Hope Rainbow
|
Phoenix, AZ
|
$500
|
Bringing dignity and comfort into the harsh world of childhood cancer and other threatening diseases.
|
2022
|
|
Mayo Clinic College of Medicine
|
Rochester, MN
|
$300K
|
Evaluate candidate glioma csf proteomic signatures to help understand and monitor glioma evolution in living patients during standard of care and experimental immunotherapy. Payment 1 of 2.
|
2022
|
|
Memorial Sloan Kettering Cancer Cen
|
New York, NY
|
$300K
|
Discover and describe dormant tumor cells called cancer STEM cells that reside within adult glioma and are resistant to current therapies. Payment 1 of 2.
|
2022
|
|
Columbia University Irving Medical
|
New York, NY
|
$250K
|
Targeting the glioblastoma master regulator cebp a pharmacokinetics and pharmacodynamics surgical study of st101. Payment 1 of 2.
|
2022
|
|
Damon Runyon Cancer Research Fdn
|
New York, NY
|
$120K
|
Investigation of a biomarker phase 2 study to evaluate targeted therapy harboring specific genetic alterations. Payment 3
|
2022
|
|
Virginia Tech
|
Roanoke, VA
|
$250K
|
To inhibit tumor cell invasion and invasion, targeted therapeutics will be coupled to biomarker-based imaging in patient-specific models of glioblastoma. Payment 2 of 2.
|
2022
|
|
Vanderbilt University
|
Nashville, TN
|
$250K
|
Using single-cell and sySTEMs biology approaches in glioblastoma, cell subtypes will be mapped to glioblastoma tissues and experimental models, enabling identification and preclinical targeting of interactions between cancer cells, immune cells, and location specific resident brain cells. Payment 2 of 2.
|
2022
|
|
H Lee Moffitt Cancer Center
|
Rochester, MN
|
$300K
|
In examining the role of tumors cells in modulating bone marrow-derived macrophages and microglia, this study seeks to tailor novel therapeutics for targeting of tumor associated macrophages. Payment 2 of 2.
|
2022
|
|
Yale Cancer Center
|
New Haven, CT
|
$300K
|
Use of a novel transformational platform for rapid identification of targets and treatments to inhibit growth and invasion of glioblastoma cells based on rapid patient sample screening using novel nano-engineering techniques. Payment 2 of 2.
|
2022
|
|
Barrow Neurological Fdn
|
Phoenix, AZ
|
$4K
|
Provides Philanthropic Support for Barrow Neurological Institute at st. Joseph's Hospital and medical center. Barrow is an international leader in the treatment, research, and education of brain and spinal diseases, conditions and injuries.
|
2022
|
|
University of Tx Md Anderson Cancer
|
Houston, TX
|
$300K
|
Project seeks to preclinically optimize novel therapeutic approaches for atrx-deficient malignant gliomas targeting g-quadruplex dna secondary structure. Payment 1 of 2.
|
2022
|
|
O'Connor Institute
|
Phoenix, AZ
|
$500
|
Advances sandra day o'connor's distinguished legacy and lifetime work to advance civics education, civic engagement and civil discourse.
|
2022
|
|
Neurotrials LLC
|
Phoenix, AZ
|
$450K
|
Cerebrospinal fluid analysis with t-gen.
|
2022
|
|
Neurotrials LLC
|
Phoenix, AZ
|
$5.5M
|
Prepayment of 2023 cerebrospinal fluid analysis.
|
2022
|
|
Neuro Trials LLC
|
Phoenix, AZ
|
$200K
|
Deposit for ivy brain tumor center building lobby.
|
2022
|
|
Univ of Miami Miller School of Medi
|
Miami, FL
|
$300K
|
USING PATIENT DERIVED ORTHOTOPIC XENOGRAFT MODELS AND A NOVEL IMMUNOCOMPETENT MODEL OF GBM, THE EFFICACY OF A MTl-MMP INHIBITOR IN COMBINATION WITH RADIATION/TMZ WILL BE TESTED TO DETERMINE ITS EFFECTS ON THE IMMUNE COMPONENT OF THE TUMOR MICROENVIRONMENT. PAYMENT 2 OF 2.
|
2022
|
|
Mayo Clinic
|
Jacksonville, FL
|
$269K
|
Identify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to effectively treat this disease. Payment 1 of 2.
|
2022
|
|
Notmykid
|
Scottsdale, AZ
|
$1K
|
Lifesaving programs, support, resources, and education to empower adn educate youth, familes, and communities with the knowledge and courage to identify and prevent negative youth behavior.
|
2022
|
|
Society of St Vincent De Paul
|
Phoenix, AZ
|
$250K
|
Center for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encourage the whole family to participate. Payment #3.
|
2022
|
|
Univ of New Mexico Health Sciences
|
Albuquerque, NM
|
$300K
|
Identify mechanisms underlying inflammatory cell contribution to the emergence of the recurrent tumor by single-cell analysis of residual disease in glioblastoma patients. Payment 2 of 2.
|
2022
|
|
University of Michigan
|
Ann Arbor, MI
|
$300K
|
New methods will be developed to measure the activity of tumor metabolic pathways in patients with glioblastoma and to determine whether drugs designed to block these pathways are suitable. Payment 2 of 2.
|
2022
|
|
Arcs Foundation
|
Artesia, CA
|
$9K
|
Advance science and technology in the united states by providing awards to academically outstanding us citizens studying to complete degrees in science, engineering and medical research.
|
2022
|
|
Swedish Medical Center
|
Seattle, WA
|
$300K
|
Assess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosySTEM with intact tumor microenvironment using multiplex immunochemistry and spatial mapping of cell types. Payment 1 of 2.
|
2022
|
|
Mayo Clinic College of Medicine
|
Rochester, MN
|
$208K
|
Immunostimulatory bacterial antigens expressed in oncolytic viral platforms will be tested in preclinical models of glioblastoma to overcome immune checkpoint inhibitor resistance. Payment 2 of 2.
|
2022
|